193 related articles for article (PubMed ID: 37099029)
1. Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and management.
Terpos E; Branagan AR; García-Sanz R; Trotman J; Greenberger LM; Stephens DM; Morel P; Kimby E; Frustaci AM; Hatjiharissi E; San-Miguel J; Dimopoulos MA; Treon SP; Leblond V
Semin Hematol; 2023 Mar; 60(2):107-112. PubMed ID: 37099029
[TBL] [Abstract][Full Text] [Related]
2. Report of consensus panel 1 from the 11
Buske C; Castillo JJ; Abeykoon JP; Advani R; Arulogun SO; Branagan AR; Cao X; D'Sa S; Hou J; Kapoor P; Kastritis E; Kersten MJ; LeBlond V; Leiba M; Matous JV; Paludo J; Qiu L; Tam CS; Tedeschi A; Thomas SK; Tohidi-Esfahani I; Varettoni M; Vos JM; Garcia-Sanz R; San-Miguel J; Dimopoulos MA; Treon SP; Trotman J
Semin Hematol; 2023 Mar; 60(2):73-79. PubMed ID: 37099027
[TBL] [Abstract][Full Text] [Related]
3. Report of Consensus Panel 6 from the 11 th International Workshop on Waldenström's Macroglobulinemia on Management of Waldenström's Macroglobulinemia Related Amyloidosis.
Merlini G; Sarosiek S; Benevolo G; Cao X; Dimopoulos M; Garcia-Sanz R; Gatt ME; Fernandez de Larrea C; San-Miguel J; Treon SP; Minnema MC
Semin Hematol; 2023 Mar; 60(2):113-117. PubMed ID: 37099030
[TBL] [Abstract][Full Text] [Related]
4. Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients.
D'Sa S; Matous JV; Advani R; Buske C; Castillo JJ; Gatt M; Kapoor P; Kersten MJ; Leblond V; Leiba M; Palomba ML; Paludo J; Qiu L; Sarosiek S; Shadman M; Talaulikar D; Tam CS; Tedeschi A; Thomas SK; Tohidi-Esfahani I; Trotman J; Varettoni M; Vos J; Garcia-Sanz R; San-Miguel J; Dimopoulos MA; Treon SP; Kastritis E
Semin Hematol; 2023 Mar; 60(2):80-89. PubMed ID: 37147252
[TBL] [Abstract][Full Text] [Related]
5. Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria.
Treon SP; Tedeschi A; San-Miguel J; Garcia-Sanz R; Anderson KC; Kimby E; Minnema MC; Benevolo G; Qiu L; Yi S; Terpos E; Tam CS; Castillo JJ; Morel P; Dimopoulos M; Owen RG
Semin Hematol; 2023 Mar; 60(2):97-106. PubMed ID: 37173155
[TBL] [Abstract][Full Text] [Related]
6. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia.
Garcia-Sanz R; Varettoni M; Jiménez C; Ferrero S; Poulain S; San-Miguel JF; Guerrera ML; Drandi D; Bagratuni T; McMaster M; Roccaro AM; Roos-Weil D; Leiba M; Li Y; Qiu L; Hou J; De Larrea CF; Castillo JJ; Dimopoulos M; Owen RG; Treon SP; Hunter ZR
Semin Hematol; 2023 Mar; 60(2):90-96. PubMed ID: 37099028
[TBL] [Abstract][Full Text] [Related]
7. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
[TBL] [Abstract][Full Text] [Related]
8. Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia.
Leblond V; Kastritis E; Advani R; Ansell SM; Buske C; Castillo JJ; García-Sanz R; Gertz M; Kimby E; Kyriakou C; Merlini G; Minnema MC; Morel P; Morra E; Rummel M; Wechalekar A; Patterson CJ; Treon SP; Dimopoulos MA
Blood; 2016 Sep; 128(10):1321-8. PubMed ID: 27432877
[TBL] [Abstract][Full Text] [Related]
9. Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN).
Terpos E; Musto P; Engelhardt M; Delforge M; Cook G; Gay F; van de Donk NWCJ; Ntanasis-Stathopoulos I; Vangsted AJ; Driessen C; Schjesvold F; Cerchione C; Zweegman S; Hajek R; Moreau P; Einsele H; San-Miguel J; Boccadoro M; Dimopoulos MA; Sonneveld P; Ludwig H
Leukemia; 2023 Jun; 37(6):1175-1185. PubMed ID: 37142661
[TBL] [Abstract][Full Text] [Related]
10. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
[TBL] [Abstract][Full Text] [Related]
11. The current role of BTK inhibitors in the treatment of Waldenstrom's Macroglobulinemia.
Gavriatopoulou M; Fotiou D; Ntanasis-Stathopoulos I; Dimopoulos MA
Expert Rev Anticancer Ther; 2020 Aug; 20(8):663-674. PubMed ID: 32631091
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic algorithm of Waldenström's macroglobulinemia or lymphoplasmacytic lymphoma in Japan].
Sekiguchi N
Rinsho Ketsueki; 2021; 62(8):1139-1148. PubMed ID: 34497201
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
[TBL] [Abstract][Full Text] [Related]
15. Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study.
Gavriatopoulou M; Terpos E; Ntanasis-Stathopoulos I; Briasoulis A; Gumeni S; Malandrakis P; Fotiou D; Migkou M; Theodorakakou F; Eleutherakis-Papaiakovou E; Kanellias N; Kastritis E; Trougakos IP; Dimopoulos MA
Blood Adv; 2021 Nov; 5(21):4398-4405. PubMed ID: 34529762
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of Waldenström macroglobulinemia.
McMaster ML
Semin Hematol; 2023 Mar; 60(2):65-72. PubMed ID: 37099032
[TBL] [Abstract][Full Text] [Related]
17. Managing Waldenström's macroglobulinemia with BTK inhibitors.
Buske C; Jurczak W; Salem JE; Dimopoulos MA
Leukemia; 2023 Jan; 37(1):35-46. PubMed ID: 36402930
[TBL] [Abstract][Full Text] [Related]
18. Low Spike Antibody Levels and Impaired BA.4/5 Neutralization in Patients with Multiple Myeloma or Waldenstrom's Macroglobulinemia after BNT162b2 Booster Vaccination.
Rosati M; Terpos E; Bear J; Burns R; Devasundaram S; Ntanasis-Stathopoulos I; Gavriatopoulou M; Kastritis E; Dimopoulos MA; Pavlakis GN; Felber BK
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497296
[TBL] [Abstract][Full Text] [Related]
19. [Waldenström's macroglobulinemia. Current developments in diagnostics and therapy].
Grunenberg A; Buske C
Internist (Berl); 2016 Mar; 57(3):238-44. PubMed ID: 26830425
[TBL] [Abstract][Full Text] [Related]
20. Current options to manage Waldenström's macroglobulinemia.
Benevolo G; Nicolosi M; Santambrogio E; Vitolo U
Expert Rev Hematol; 2017 Jul; 10(7):637-647. PubMed ID: 28592170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
